Company intelligence / Profile preview

Sagmel

Libertyville, Illinois, United States
Ownership
Private
Employees
~1000
Development stage
Other
01

Overview

Sagmel, Inc. was a privately held pharmaceutical company headquartered in Libertyville, Illinois, specializing in the development, manufacturing, and marketing of over-the-counter (OTC) medications and nutritional supplements. The company established a dominant market presence in the Commonwealth of Independent States (CIS), including Russia, Ukraine, Kazakhstan, and Belarus, where it became a leading provider of consumer health products. Its portfolio featured well-known brands such as Theraflex for joint health, Nazol for nasal congestion, and Relief for hemorrhoid treatment. In 2008, Sagmel was acquired by Bayer HealthCare for approximately €265 million, significantly expanding Bayer's footprint in the rapidly growing Eastern European and CIS markets. Following the acquisition, Sagmel's operations and brand assets were fully integrated into Bayer's Consumer Care division.

Therapeutic areas
EndocrinologyPulmonologyRheumatologyGastroenterologyMetabolic Disorders
Modalities
Small molecule
Industry
Biotech
02

Drug pipeline

1 asset

Nazol

Unknown
03

Partnerships

Bayer

Beyond the preview

Go deeper on Sagmel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sagmel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call